Sandoz Group AG (OTCMKTS:SDZNY – Get Free Report) fell 1% on Friday . The stock traded as low as $44.46 and last traded at $44.62. 23,381 shares changed hands during trading, a decline of 31% from the average session volume of 33,707 shares. The stock had previously closed at $45.06.
Wall Street Analysts Forecast Growth
Separately, BNP Paribas downgraded Sandoz Group from a “strong-buy” rating to a “hold” rating in a research report on Monday, December 2nd.
View Our Latest Stock Report on SDZNY
Sandoz Group Trading Down 1.0 %
About Sandoz Group
Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology, as well as bone disease.
Recommended Stories
- Five stocks we like better than Sandoz Group
- What is a Secondary Public Offering? What Investors Need to Know
- AI Demand Sparks Opportunities for These 3 Nuclear Energy Leaders
- Canadian Penny Stocks: Can They Make You Rich?
- TSMC: Long-Term Outlook Still Strong as Geopolitical Risk Rises
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Uber’s NVIDIA Deal and Buybacks Signal Major Upside
Receive News & Ratings for Sandoz Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sandoz Group and related companies with MarketBeat.com's FREE daily email newsletter.
